BURLINGTON, Mass., Nov. 10, 2023 /PRNewswire/ -- Azenta, Inc.
(Nasdaq: AZTA) today announced that Company management will
participate in the Stephens Annual Investment Conference in
Nashville, Tennessee, on
Wednesday, November 15, 2023, and
Thursday, November 16, 2023. The
company will host a presentation on Thursday, November 16, 2023, beginning at
11:00 am CT. The live webcast can be
accessed through the Azenta investor relations website
at https://investors.azenta.com/events. A replay of the
webcast will be available following the event.
About Azenta Life Sciences
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life
sciences solutions worldwide, enabling impactful breakthroughs and
therapies to market faster. Azenta provides a full suite of
reliable cold-chain sample management solutions and multiomics
services across areas such as drug development, clinical research
and advanced cell therapies for the industry's top pharmaceutical,
biotech, academic and healthcare institutions globally. Our global
team delivers and supports these products and services through our
industry-leading brands, including GENEWIZ, FluidX, Ziath, 4titude,
Limfinity, Freezer Pro, Barkey and B Medical Systems.
Azenta is headquartered in Burlington,
MA, with operations in North
America, Europe and
Asia. For more information, please
visit www.azenta.com.
INVESTOR CONTACTS:
Sara Silverman
Head of Investor Relations & Corporate Communications
ir@azenta.com
Sherry Dinsmore
sherry.dinsmore@azenta.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/azenta-to-participate-in-the-stephens-annual-investment-conference-301984958.html
SOURCE Azenta